Clarify, revise protocol for phase 3 trial of Dengue Tetravalent Vaccine: CDSCO panel tells Panacea Biotec Medical Dialogues Team2 Oct 2021 11:30 AM ISTNew Delhi: In response to Panacea Biotec's proposal to conduct a phase 3 clinical trial of its Dengue Tetravalent Vaccine, the Subject Expert...
Cadila Healthcare gets CDSCO panel nod to conduct phase 3 study of ZydCov-D in 2-dose schedule Medical Dialogues Team29 Sept 2021 4:47 PM ISTNew Delhi: In a major rejoice to Cadila Healthcare, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Submit detailed rationale for developing Pantoprazole modified dosage form: CDSCO panel tells Lupin Medical Dialogues Team28 Sept 2021 6:01 PM ISTNew Delhi: In response to drug-maker Lupin's proposal of manufacturing and marketing Pantoprazole enteric coated delayed release tablets 40 mg...
Mylan gets CDSCO panel nod to import, market Cutaneous Cryogenic Spray of Endwarts Freeze Medical Dialogues Team26 Sept 2021 11:00 AM ISTNew Delhi: Mylan Pharmaceuticals has received approval from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Intas secures CDSCO panel nod to study arthritis drug Adalimumab Medical Dialogues Team24 Sept 2021 5:08 PM ISTNew Delhi: In a significant development, drug firm Intas has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Ampio Pharma wins DCGI nod to begin AP-019 study to treat Covid-linked respiratory distress Ruchika Sharma24 Sept 2021 12:00 PM ISTEnglewood: Ampio Pharmaceuticals, a biopharmaceutical company has recently announced regulatory approval from the Drugs Controller...
Roche antibody cocktail for post-exposure prophylaxis of Covid-19 for adults gets CDSCO panel okay Medical Dialogues Team21 Sept 2021 5:05 PM ISTNew Delhi: With the aim of reducing the spread of the Covid-19 epidemic, the Subject Expert Committee (SEC), functional under the Central Drug...
Hetero gets CDSCO panel nod to manufacture Sputnik V for restricted emergency use Medical Dialogues Team21 Sept 2021 4:20 PM ISTNew Delhi: In a significant development, drug firm Hetero has got the green signal from the Subject Expert Committee (SEC) functional under the...
CDSCO approves Exablate neuro focused ultrasound platform Ruchika Sharma21 Sept 2021 12:08 PM ISTIsrael: Global healthcare company, Insightec, has recently announced that its incisionless neurosurgery platform, the Exablate 4000, has...
CoSara Diagnostics gets CDSCO clearance for chikungunya, dengue tests Ruchika Sharma20 Sept 2021 1:10 PM ISTSalt Lake City: Co-Diagnostics, Inc. has recently announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India,...
CDSCO raises alert on Medtronic HeartWare HVAD System, physicians asked to cease new implants Medical Dialogues Team19 Sept 2021 11:30 AM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued a Medical Device Alert for Medtronic's HeartWare Ventricular Assist...
Sanofi plea for Insulin Glargine, Lixisenatide antidiabetic combination rejected by CDSCO panel Medical Dialogues Team16 Sept 2021 4:14 PM ISTNew Delhi: In a major setback to Sanofi India Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
